Looking Glass: Bimanual Balanced Reaching With Visual Biofeedback
Bimanual Balanced Reaching With Visual Biofeedback
1 other identifier
interventional
75
1 country
1
Brief Summary
The goal of this research study is to increase understanding of error augmentation by applying it to visual feedback during motion tracking with a Leap Motion device - a recently developed optical hand tracking tool - and the LookingGlass - a new, portable virtual reality environment. In conjunction with the Leap, large, three dimensional work spaces can provide an immersive and virtual augmented environment for rehabilitation. Previously, experiments have utilized the Virtual Reality Robotic and Optical Operations Machine (VRROOM) to create such visually immersive environments. The Robotics lab as part of the Arms and Hands Lab on the 22nd floor of the Shirley Ryan Abilitylab has developed a portable version of this system, which is more compact and clinic-compatible. Combining this visual 3D system with the Leap creates a novel, more capable apparatus for studying error augmentation. This research study will have 3 different arms: 1.) a healthy group of individuals (Healthy Arm), 2.) a group of stroke survivors within 8 months of stroke (Acute Arm), and 3.) a group of stroke survivors that had their stroke more than 8 months ago (Chronic Arm). Each Arm will use the Leap motion tracker and the Looking Glass to participate in a reaching intervention. The healthy arm will only participate in 1 visit with an intervention with and without error augmented visual feedback. The Acute Arm and the Chronic Arm will both have 2 groups: 1.) Error Augmented Visual Feedback group and 2.) Non-Augmented or Veridical Visual Feedback group. The Chronic Arm will have a structured intervention and evaluation protocol: Study staff will administer outcome assessments at 3 time points: a.) prior to intervention, b.) post intervention, and c.) 2 months after the conclusion of intervention. Intervention will occur over the span of 6-8 weeks with the goal of 3 1-hour sessions per week. The Acute Arm will have a less structured intervention that will occur while the participant is an inpatient at Shirley Ryan AbilityLab. Study staff will administer outcome assessments at at least 2 time points: a.) prior to intervention, b.) post intervention just prior to discharge from Shirley Ryan AbilityLab. Between initial and post intervention evaluations, midpoint evaluations will take place at a maximum of once per week if the participant's schedule, activity tolerance, and length of stay allows. Intervention will consist of 1-hour sessions occurring according to the availability of the participant at the rate of no more than 2 sessions in a 24 hour period. Investigators hope to investigate these questions:
- 1.Can the movement of healthy individuals be characterized with error augmented visual feedback and veridical visual feedback?
- 2.Will error augmented visual feedback or veridical visual feedback result in greater movement ability improvement?
- 3.Is treatment with the looking glass and leap system feasible with an inpatient population?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Aug 2017
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 8, 2017
CompletedFirst Submitted
Initial submission to the registry
September 13, 2017
CompletedFirst Posted
Study publicly available on registry
October 3, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
October 24, 2024
September 1, 2024
9.3 years
September 13, 2017
October 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fugl Meyer Upper Extremity Score: Pre to Post/Discharge - Chronic and Acute Arms
Change in Fugl Meyer score from pre-evaluation to post -evaluation
1-3 weeks for acute arm; 9 weeks for chronic arm
Secondary Outcomes (4)
Fugl Meyer Upper Extremity Score: Pre to Follow-up
4.5 months
Amount of use
1-3 weeks, on average
Action Research Arm Test Score: Pre to Post
1-3 weeks for acute arm; 9 weeks for chronic arm
Action Research Arm Test Score: Pre to Follow-Up
4.5 months
Study Arms (5)
Healthy
ACTIVE COMPARATORHealthy participants will participate in reaching activity using the Looking Glass and Leap motion tracking system
Chronic Veridical Visual Feedback
EXPERIMENTALReaching while sitting at the Looking Glass system. The representation of arm movements will directly reflect the participants actual arm movements.
Chronic Augmented Visual Feedback
EXPERIMENTALReaching while sitting at the Looking Glass system. The representation of a participant's arm movements will be augmented to encourage different movement patterns and improved movement.
Acute Veridical Visual Feedback
EXPERIMENTALReaching while sitting at the Looking Glass system. The representation of arm movements will directly reflect the participants actual arm movements.
Acute Augmented Visual Feedback
EXPERIMENTALReaching while sitting at the Looking Glass system. The representation of a participant's arm movements will be augmented to encourage different movement patterns and improved movement.
Interventions
Reaching while sitting at the Looking Glass system. The representation of arm movements will directly reflect the participants actual arm movements.
Reaching while sitting at the Looking Glass system. The representation of a participant's arm movements will be augmented to encourage different movement patterns and improved movement.
Reaching while sitting at the Looking Glass system. This will occur over the course of 1 hour.
Eligibility Criteria
You may qualify if:
- months post stroke
- FMUE 15-50
- Active shoulder and elbow flexion-extension when supported against gravity to accomplish a forward mediolateral and inferior-superior reaching movements of 30 cm
You may not qualify if:
- Bilateral paresis
- Severe sensory deficits in the affected limb
- Severe spasticity preventing movement (MAS 4 or greater at elbow)
- Aphasia, cognitive impairment or affective dysfunction that influence ability to participate in the experiment
- Inability to provide informed consent
- Severe current medical problems
- Diffuse/multiple lesion sites or multiple strokes
- Hemi-spatial neglect or visual field cut preventing subjects from seeing the target
- Inability to maintain the testing positions
- Botox injections in the affected Upper Extremity within the past 4 months
- Concurrent participation in Upper Extremity rehab (research or prescribed therapy)
- Participation in previous, similar robotics intervention studies
- Pregnant women, children and teenagers, prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shirley Ryan AbilityLab
Chicago, Illinois, 60610, United States
Related Publications (1)
Celian C, Puzzi T, Verardi M, Olavarria E, Porta F, Pedrocchi A, Patton JL. Does visual error augmentation offer advantages during bimanual therapy in individuals poststroke? A randomized controlled trial. J Int Med Res. 2025 Aug;53(8):3000605251361115. doi: 10.1177/03000605251361115. Epub 2025 Aug 9.
PMID: 40781976DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James Patton
Shirley Ryan AbilityLab and University of Illinois at Chicago (UIC)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-Director, Robotics Laboratory, Arms and Hands Lab, Shirley Ryan AbilityLab
Study Record Dates
First Submitted
September 13, 2017
First Posted
October 3, 2017
Study Start
August 8, 2017
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
October 24, 2024
Record last verified: 2024-09